Edition:
United Kingdom

China Shineway Pharmaceutical Group Ltd (2877.HK)

2877.HK on Hong Kong Stock

10.28HKD
19 Oct 2018
Change (% chg)

-- (--)
Prev Close
HK$10.28
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,684,314
52-wk High
HK$18.54
52-wk Low
HK$6.67

Summary

Name Age Since Current Position

Zhenjiang Li

62 Executive Chairman of the Board, President

Bun Ching Lee

45 2017 Financial Controller, Company Secretary

Zhong Chen

51 2015 Executive Director

Huimin Li

50 Executive Director

Yunxia Xin

54 Executive Director

Li Cheng

58 2006 Independent Non-Executive Director

Guoan Luo

71 2017 Independent Non-Executive Director

Liutai Sun

54 2010 Independent Non-Executive Director

King Kuen Hung

50 2017 IR Contact

Biographies

Name Description

Zhenjiang Li

Mr. Li Zhenjiang serves Executive Chairman of the Board, President of China Shineway Pharmaceutical Group Ltd. Mr. Li obtained an EMBA degree from the Yangtze Commercial Institute. Mr. Li joined the predecessor of the Group in 1974 and has been the Chairman and President of the Group and its predecessor since 1984 with responsibility for business development and strategy. He has more than 20 years’ experience in the operation and management of modern Chinese medicine enterprises. Mr. Li takes charge of the overall management of the Group and is also specifically responsible for the Group’s research and development activities. Mr. Li is a Representative to the 10th and 11th National People’s Congress. He was named as an Outstanding Entrepreneur in the PRC Pharmaceutical Industry in 1994 and has received a National Wu Yi Labour Award and special subsidies of the State Council. Mr. Li is the vice-chairman of the PRC Chinese Medicine Association. Mr. Li is also directors of several members of the Group.

Bun Ching Lee

Mr. Lee (Terence) Bun Ching serves as Financial Controller, Company Secretary of China Shineway Pharmaceutical Group Limited. Mr. Lee is a member of the Hong Kong Institute of Certified Public Accountants and American Institute of Certified Public Accountants. He holds a bachelor’s degree in Accounting and Financial Analysis and a master’s degree in Economics and Finance from the University of Warwick in the United Kingdom. Mr. Lee has extensive work experience in the field of auditing, accounting, finance and taxation. Prior to joining the Group, he served as the Group Accounting Controller of a listed company in Hong Kong for over 3 years. Between 1996 and 2007, Mr. Lee worked in a reputable international accounting firm and was a Senior Manager when he left in 2007. He joined the Group in 2011.

Zhong Chen

Mr. Chen Zhong serves as Executive Director of the Company. He was Deputy General Manager, Executive Director of China Shineway Pharmaceutical Group Ltd. He is qualified as a chief senior engineer and is a certified pharmacist. He graduated from Hebei Medical University in 1990 with a bachelor’s degree in pharmacy. Mr. Chen is a leader of Modern Traditional Chinese Medicines Manufacturing Technology of Hebei Province, chief officer of the National and Local United Engineering Laboratory for the Development Technology of New Chinese Medicine Injection, chief officer of Chinese Medicine Injection Engineering and Technology Research Centre in Hebei Province, general vice-officer of National-Recognition on Enterprise Technology Centre, deputy officer of specialized committee of traditional Chinese medicines on economic in China Association of Traditional Chinese Medicine and price review expert on medicines in National Development and Reform Commission of the People’s Republic of China. Mr. Chen joined the predecessor of the group in 1990 and is currently the vice president of the Shineway Pharmaceutical Group Limited (formerly known as Shineway Pharmaceutical Company Limited), director of Hebei Shineway Pharmaceutical Company Limited, director of Xizang Shineway Pharmaceutical Company Limited and director of Shineway Pharmaceutical (Hainan) Company Limited. He is responsible for quality control on production and technology management activities of the Company’s group with over 20 years of experience.

Huimin Li

Mr. Li Huimin is Executive Director of China Shineway Pharmaceutical Group Limited. He graduated from Hebei Party School in 1997 where he majored in economic administration. He is primarily responsible for the marketing and sales of the Group’s products and, since joining the predecessor of the Group in 1992, focused on sales and marketing. Immediately prior to the corporate reorganisation in preparation of the listing of the Company in 2004, Mr. Li was the sales and marketing manager of Shineway Medical. He has developed a deep understanding of sales management in the PRC Chinese medicine industry with more than 15 years’ experience. Mr. Li is a vice-chairman of Hong Kong Chinese Prepared Medicine Traders Association since 2010.

Yunxia Xin

Ms. Xin Yunxia serves as an Executive Director of China Shineway Pharmaceutical Group Limited. Ms. Xin graduated from the Yangtze Commercial Institute with an EMBA degree. Ms. Xin is primarily responsible for the Group’s human resources management and operation. Ms. Xin joined the predecessor of the Group in 1981, focused on administration. She was the Deputy General Manager (human resources management) of Shineway Medical Science & Technology Co., Ltd. (“Shineway Medical”) immediately prior to the corporate reorganisation in preparation of the listing of the Company in 2004. Ms. Xin has more than 20 years’ experience in business management in the industry with the Group.

Li Cheng

Ms. Cheng Li serves as an Independent Non-Executive Director of China Shineway Pharmaceutical Group Limited. She has a legal science bachelor’s degree and the legal science master’s degree from the law department of Japan Special Training University. She also studied in Sino-Japanese Investment Trade Promotion Association. She joined Commerce & Finance Law Office in 1995 and became a partner of Commerce & Finance Law Office since 2002. She is currently a member of Beijing Lawyer Association.

Guoan Luo

Prof. Luo Guoan is an Independent Non-Executive Director of the Company. He graduated with biochemical engineering profession, and subsequently obtained master degree in chemistry from East China University of Science and Technology. Prof. Luo is the head of the Collaboration Centre of Network for Traditional Chinese Medicine of National Education Ministry, professor and doctoral tutor of Department of Chemistry in Tsinghua University. Prof. Luo is currently the committee chairman of the biopharmaceutical technology branch of China Medicinal Biotech Association, council chairman of the National Conference on Pharmaceutical Analysis and the chairman of Chinese Medicine Product Development and Cultivation of Professional Committee in China Association of Traditional Chinese Medicine. Prof. Luo is a well-known expert in the field of Chinese medicine analysis and quality control. He has long been engaged in drug analysis and traditional Chinese medicine systems and biological research. He has published a book titled “Systems Biology for Traditional Chinese Medicine” which is an international publication of traditional Chinese medicine system biology monographs.

Liutai Sun

Mr. Sun Liutai serves as an Independent Non-Executive Director of China Shineway Pharmaceutical Group Limited. He has studied postgraduate programme in Economic Management Institute of North Western University. Mr. Sun has sound experience in accounting profession and finance. In 2003, he was appointed by Hebei Securities and Futures Commission to investigate a company listed on Shenzhen Stock Exchange. He worked as an assistant manager of general strategic department in China Investment Bank Hebei branch from 1987 to 1992, and worked as an assistant general manager in a Hebei Investment Management Consultancy Company in 1992 to 1995. He then worked as a principal accountant in Hebei Yongzhengde Certified Public Accountants from 1995 to 2002, during which he was engaged in audit of a company listed on the Shanghai Stock Exchange. Mr. Sun was appointed as a partner of Hebei Peking Certified Public Accountants from 2002 to present. Mr. Sun was a general committee of Hebei Society of Certified Public Accountants in 2002 to 2008, and was employed as an independent director and audit in-charge of Qinhuangdao Yaohua Glass Co., Ltd. (a company listed on the Shanghai Stock Exchange, stock code: 600716) from May 2002 to June 2008. He is a Chinese Certified Public Accountant.

King Kuen Hung

Mr. Hung (Randy) King Kuen is IR Contact of the Company. He was Independent Non-Executive Director of China Shineway Pharmaceutical Group Ltd. He was appointed as an non-executive Director in 2011, and was re-designated to independent non-executive Director in 2014. Mr. Hung holds an MBA degree from the University of London, a bachelor’s degree of science in accounting and a certificate of programming and data processing from the University of Southern California, a certificate of China Accounting, Finance, Taxation and Law from the Chinese University of Hong Kong and a Hong Kong Securities Institute Specialist Certificate in corporate finance. He has extensive experience in corporate finance and investor relation. Mr. Hung is currently an executive director and chief financial officer of China Fiber Optic Network System Group Limited (stock code: 3777), and an independent non-executive director of Zhongyu Gas Holdings Limited (stock code: 3633). Mr. Hung is a fellow of the Hong Kong Institute of Certified Public Accountants, a member of the American Institute of Certified Public Accountants, a member of the Hong Kong Securities Institute, a vice chairman of the Hong Kong Investor Relations Association and a council member of the Hong Kong Institute of Directors.

Basic Compensation

Name Fiscal Year Total

Zhenjiang Li

4,363,000

Bun Ching Lee

--

Zhong Chen

1,937,000

Huimin Li

1,253,000

Yunxia Xin

2,773,000

Li Cheng

130,000

Guoan Luo

71,000

Liutai Sun

130,000

King Kuen Hung

33,000
As Of  31 Dec 2017

Options Compensation